**Summary of BSF Enterprise PLCs Annual Financial Report (2025):**
BSF Enterprise PLC, a leader in tissue-engineered materials, released its Annual Report for the year ended September 30, 2025, highlighting significant progress across its subsidiaries and strategic initiatives.
**Key Highlights**
1. **Commercial and Technical Progress**
Subsidiaries 3D Bio-Tissues (3DBT), Lab-Grown Leather (LGL), and Kerato achieved notable advancements.
Launched CytoBoostâ„¢ bioactive media additive and expanded City-Mixâ„¢ for cost-effective cultivated meat production.
Developed the worlds first 2mm-thick scaffold-free leather, collaborating with luxury fashion brands.
Secured a licensing agreement with the University of Montreal for liquid cornea technology, with veterinary trials planned for 2026 and human trials in 2027.
2. **Financial Performance**
Reduced net loss to £1,013,527 (from £1,672,291 in 2024) due to cost control and increased grant income.
Strategic fundraising initiatives, including shareholder approval for up to £15 million via warrants, to support commercialization, spin-outs, and expansion in Greater China.
3. **Strategic Achievements**
Expanded into Greater China, laying the foundation for local cultivated meat production.
Strengthened sustainability and ESG commitments, aligning with the Task Force on Climate-Related Financial Disclosures (TCFD).
4. **Future Plans (2026)**
Commercialize CytoBoost™ and City-mixⓇ.
Scale up lab-grown leather production and produce T-Rex leather for sale.
Complete veterinary clinical trials for corneal implants, advancing toward human trials in 2027.
Expand cultivated meat production in Greater China.
Explore acquisitions of compatible businesses.
**Financial Summary**
Revenue: £52840 (2024: £57821)
Loss before taxation: £1216970 (2024: £1797506)
Loss for the year: £1113527 (2024: £1672291)
Cash and cash equivalents: £149020 (2024: £637656)
**Corporate Governance and Sustainability:**
Committed to ethical valuesshareholder engagementand sustainability.
Adopted anti-bribery and anti-corruption policies.
Focused on diversity and environmental responsibility, aligning with TCFD recommendations.
**Conclusion**
BSF Enterprise PLC demonstrated significant progress in 2025, with strategic advancements, reduced losses, and a clear roadmap for 2026. The company is well-positioned for long-term growth in sustainable, tissue-engineered materials, supported by strong governance and sustainability commitments.